Records containing: Large-cell Lymphoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-20
A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With B-cell Malignancies
CLINICAL_TRIALS study record update · 2026-03-02
Rapcabtagene Autoleucel for Eradication of Measurable Residual Disease in Large B-Cell Lymphoma (LBCL)
CLINICAL_TRIALS study record update · 2025-10-09
Evaluation of a Communication Intervention (Hematolo-GIST) for Large B-Cell Lymphoma Providers
CLINICAL_TRIALS study record update · 2025-07-04
Transplantation of Umbilical Cord Blood From Unrelated Donors in Patients With Hematological Diseases Using a Non-Myeloablative Preparative Regimen
CLINICAL_TRIALS study record update · 2025-02-21
Open-Label, Phase 1 Study of CD19 t-haNK In Subjects With Diffuse Large B-Cell Lymphoma Who Have Received 2 Or More Lines of Therapy And Are Ineligible For Transplant
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-02-10
Telehealth-based Symptom Management for Veterans Treated With Selinexor
CLINICAL_TRIALS study record update · 2020-07-24
Adoptive Transfer of T Regulatory Cell for Suppression of Acute Graft-vs-Host-Disease After an Umbilical Cord Blood Transplant for Hematologic Malignancies
CLINICAL_TRIALS study record update · 2017-05-12
A First-in-human, Single-arm, Single-center, Open-label, Proof-of-concept Study to Evaluate the Safety and Tolerability of Infusing HSC835 (LFU835-expanded Umbilical Cord Blood Hematopoietic Stem Cells) in Patients With Hematological Malignancies